Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
Cancer Sci. 2010 Sep;101(9):1965-9. doi: 10.1111/j.1349-7006.2010.01634.x.
Growth of colon carcinoma cells transfected with mucin 1 (MUC1) was effectively suppressed by vaccination with MUC1 cDNA. The suppression was dependent on the presence of Fas ligand (FasL) in the cecum, whereas it was independent of FasL in the spleen and in the liver, as revealed by the use of gld/gld mice as the recipients of vaccination, and transplantation of tumor cells expressing MUC1. CD4(+) T cells were transferred from mice immunized with MUC1 cDNA to naive gld/gld or C57BL/6 mice, and the suppression of colon carcinoma growth in the cecum was tested. The results clearly showed that FasL in the recipient played a significant role. In the cecum, FasL was associated with intratumoral CD11b(+) cells, which are likely to be responsible for vaccine-induced tumor suppression. The T cell response to MUC1 was not influenced by the gld/gld status.
转染黏蛋白 1(MUC1)的结肠癌细胞的生长被 MUC1 cDNA 疫苗接种有效地抑制。这种抑制依赖于盲肠中 Fas 配体(FasL)的存在,而在脾脏和肝脏中则不依赖于 FasL,这是通过使用 gld/gld 小鼠作为疫苗接种的受体,并移植表达 MUC1 的肿瘤细胞来揭示的。从用 MUC1 cDNA 免疫的小鼠中转移 CD4(+) T 细胞到未免疫的 gld/gld 或 C57BL/6 小鼠中,并测试对盲肠结肠癌生长的抑制作用。结果清楚地表明,受体中的 FasL 起着重要作用。在盲肠中,FasL 与肿瘤内的 CD11b(+)细胞相关,这些细胞可能负责疫苗诱导的肿瘤抑制。对 MUC1 的 T 细胞反应不受 gld/gld 状态的影响。